Dataset Information

Impact of carbon dioxide removal technologies on deep decarbonization of the electric power sector.

ABSTRACT: Carbon dioxide removal technologies, such as bioenergy with carbon capture and direct air capture, are valuable for stringent climate targets. Previous work has examined implications of carbon removal, primarily bioenergy-based technologies using integrated assessment models, but not investigated the effects of a portfolio of removal options on power systems in detail. Here, we explore impacts of carbon removal technologies on electric sector investments, costs, and emissions using a detailed capacity planning and dispatch model with hourly resolution. We show that adding carbon removal to a mix of low-carbon generation technologies lowers the costs of deep decarbonization. Changes to system costs and investments from including carbon removal are larger as policy ambition increases, reducing the dependence on technologies like advanced nuclear and long-duration storage. Bioenergy with carbon capture is selected for net-zero electric sector emissions targets, but direct air capture deployment increases as biomass supply costs rise.

SUBMITTER: Bistline JET

PROVIDER: S-EPMC8211809 | biostudies-literature |

REPOSITORIES: biostudies-literature

ACCESS DATA

Similar Datasets

Project description:Mechanical ventilation (MV) represents a lifesaving treatment for patients with respiratory failure, but it could be harmful through the development of ventilator-induced lung injury (VILI). In patients with acute respiratory distress syndrome (ARDS), protective MV strategies with low tidal volume to minimize VILI have been demonstrated to reduce lung injury and mortality. However, they can be limited by the emergence of uncontrolled hypercapnia. Similarly, in COPD patients, noninvasive MV failure often is associated with a progressive rise in arterial CO2 and need for endotracheal intubation, with higher risk of hospital mortality. Minimally invasive extracorporeal CO2 removal systems (ECCO2R) theoretically can remove the entire amount of the CO2 produced in the body per minute. In ARDS patients, ECCO2R may further reduce the risk of VILI ensuring ultraprotective MV and avoiding hypercapnia. In patients with exacerbation of COPD, ECCO2R may help to avoid intubation or facilitate weaning from invasive MV. In intensive care unit, concomitant renal and respiratory failure with MV is one of the strongest risk factors for hospital mortality. Combining ECCO2R and renal replacement therapy may support respiratory and renal functions and limit the side effects of MV. However, the need for systemic anticoagulation and the related risk of bleeding still represent a concern for a wider application of ECCO2R devices. In conclusion, ECCO2R is an effective support therapy to MV to limit its invasiveness and side effects, but its efficacy and safety must be proven in well-designed clinical trials. Objectives This chapter will:1 Explain the physiology of CO2 removal during extracorporeal support.2 Describe potential clinical applications of extracorporeal CO2 removal systems (ECCO2R) support therapy in patients with acute respiratory distress syndrome (ARDS) and chronic obstructive pulmonary disease (COPD) as well as in those with acute kidney injury requiring renal replacement therapy.

Dataset Information

Impact of carbon dioxide removal technologies on deep decarbonization of the electric power sector.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets